[Effect of parlodel and thyroliberin on prolactin secretion in patients with fibrocystic mastopathy].
The results are presented of parlodel use in 20 patients with diffuse fibrous-cystic mastopathy before and during parlodel treatment. It was shown that the prolactin level is on the upper limit of normal in the majority of untreated patients. Prolactin response to thyroliberin stimulation is markedly intensified. A good clinical effect and normalization of the prolactin basal level are seen during prolactin therapy, its content being augmented under thyrotropin-releasing hormone action.
D000328:Adult; D001941:Breast Diseases / Q000503:physiopathology*; D001971:Bromocriptine / Q000627:therapeutic use*; D005260:Female; D005348:Fibrocystic Breast Disease / Q000188:drug therapy / Q000503:physiopathology*; D006727:Hormone Antagonists; D006728:Hormones; D006801:Humans; D008875:Middle Aged; D010903:Pituitary Gland, Anterior / Q000503:physiopathology; D011388:Prolactin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D013268:Stimulation, Chemical; D013973:Thyrotropin-Releasing Hormone
D006727:Hormone Antagonists; D006728:Hormones; D001971:Bromocriptine; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin
Vliianie parlodela i tiroliberina na sekretsiiu prolaktina u bol'nykh fibrozno-kistoznoĭ mastopatieĭ.